Generic medicine

Montelukast 10mg Chewable Tablet

Reviewed educational reference: what Montelukast is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Montelukast
Strength
10mg
Dosage form
Chewable Tablet
Drug class
Leukotriene receptor antagonist

Related products

No reviewed products are currently published for this generic.

Montelukast 10mg Chewable Tablet contains Montelukast, a potent leukotriene receptor antagonist. It is primarily used for the long-term management of asthma and the relief of symptoms associated with seasonal allergic rhinitis. By blocking the action of leukotrienes, which are inflammatory chemicals released by the body during an allergic reaction, Montelukast 10mg Chewable Tablet helps to reduce swelling in the airways and decrease mucus production, making it easier to breathe.

At a glance

Quick look

Montelukast 10mg Chewable Tablet is a leukotriene receptor antagonist.

How it works

It prevents airway inflammation and bronchoconstriction.

Who it is for

It is used for the long-term management of asthma and allergic rhinitis.

Uses it for
Asthma prophylaxisAllergic rhinitisExercise-induced bronchoconstrictionChronic airway inflammationMaintenance therapySeasonal allergy relief

Uses of Montelukast

  • Prophylaxis and chronic treatment of asthma
  • Prevention of exercise-induced bronchoconstriction
  • Relief of daytime and nighttime symptoms of allergic rhinitis
  • Management of seasonal allergies
  • Reduction of airway inflammation in chronic asthma
  • Maintenance therapy to reduce reliance on rescue inhalers

Benefits of Montelukast

Improved Respiratory Control
By consistently blocking the effects of leukotrienes, Montelukast 10mg Chewable Tablet provides a stable reduction in airway inflammation. This leads to fewer asthma attacks and a significant decrease in the frequency of using rescue inhalers, allowing for a better quality of life and more consistent physical activity.

Convenience and Ease of Administration
The chewable tablet form is particularly beneficial for patients who have difficulty swallowing conventional tablets. It is taken once daily, usually in the evening, which simplifies the treatment regimen and improves adherence to the prescribed therapy compared to medications that require multiple daily doses.

Side effects of Montelukast

While generally well-tolerated, Montelukast 10mg Chewable Tablet may cause side effects in some individuals. Common reactions include headache, abdominal pain, and upper respiratory tract infections. Some patients may report cough, fever, or mild gastrointestinal discomfort such as diarrhea or nausea. In rare instances, users have reported neuropsychiatric events including vivid dreams, sleep disturbances, irritability, or anxiety. If you experience any persistent or concerning symptoms, contact your healthcare provider immediately. Seek emergency medical attention if you notice signs of a severe allergic reaction, such as hives, swelling of the face or throat, or difficulty breathing.

Side effectHow commonHow severeWhat to do
HeadacheCommonMildTake with a glass of water and rest.
Abdominal painCommonMildTake the medication with a small amount of food.
Neuropsychiatric eventsRareModerateObserve for changes in mood or behavior.

How to manage side effects

Headache

  • Monitor frequency.
  • Consult a doctor if the headache becomes severe or persistent.

Abdominal pain

  • Ensure the tablet is chewed properly.
  • Report if pain is sharp or accompanied by vomiting.

Neuropsychiatric events

  • Discontinue use if significant behavioral changes occur.
  • Seek medical evaluation immediately.

How to use Montelukast

  • Chew the tablet thoroughly before swallowing; do not swallow it whole.
  • Take your dose once daily in the evening, regardless of whether you have asthma or allergic rhinitis.
  • Follow the exact dosage prescribed by your physician; do not increase or decrease the dose without consultation.
  • Continue taking Montelukast 10mg Chewable Tablet even if your symptoms appear to be under control, as it is a maintenance medication, not a rescue inhaler for acute attacks.

Special population advice

Kidney impairment

  • No dosage adjustment is necessary for patients with renal insufficiency.

Liver impairment

  • Use with caution in patients with mild to moderate hepatic impairment.
  • No specific dose recommendation for severe impairment.

Children

  • Use age-appropriate formulations.
  • Ensure the child is capable of chewing the tablet safely.

Elderly

  • No specific dosage adjustment is required based on age alone.

How Montelukast works

Montelukast acts as a selective and orally active antagonist of the cysteinyl leukotriene receptor (CysLT1). Leukotrienes are inflammatory mediators released from mast cells and eosinophils that cause bronchoconstriction, mucus secretion, and vascular permeability in the lungs. By binding to these receptors, Montelukast prevents the inflammatory cascade, thereby relaxing bronchial smooth muscle and reducing airway swelling.

What if you miss or exceed a dose?

If you miss a dose

If you miss a dose of Montelukast 10mg Chewable Tablet, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time to make up for a forgotten one, as this increases the risk of side effects.

In case of overdose

An overdose of Montelukast 10mg Chewable Tablet may lead to symptoms such as abdominal pain, sleepiness, thirst, headache, vomiting, and psychomotor hyperactivity. If you suspect an overdose, contact your local poison control center or seek immediate medical attention at the nearest emergency department, even if no symptoms are currently present.

AntidoteNo specific antidote

Treatment is supportive and symptomatic.

Observation
Monitor the patient for clinical signs of toxicity, particularly neuropsychiatric changes.
Gastric Decontamination
Consider activated charcoal if ingestion is recent and the patient is conscious.
Supportive Care
Maintain airway and provide symptomatic treatment for gastrointestinal or neurological symptoms.
Dialysis
There is no evidence that Montelukast is removed by dialysis.

Safety and precautions

When to avoid Montelukast

Do not take if you
  • Hypersensitivity

    Do not use if you have a known allergy to Montelukast or any inactive ingredients.

  • Acute Asthma Attack

    This medication is not intended for the treatment of acute bronchospasm.

Use with caution
  • Neuropsychiatric disorders

    Monitor for changes in behavior or mood.

  • Hepatic impairment

    Use with caution in patients with liver disease.

  • Phenylketonuria

    Chewable tablets may contain phenylalanine; check the label.

  • Systemic corticosteroids

    Do not abruptly discontinue steroids when starting Montelukast 10mg Chewable Tablet.

Safety at a glance

AlcoholSafe

Alcohol does not directly interact with Montelukast, but it may worsen asthma symptoms in some individuals.

PregnancyConsult your doctor

Use only if clearly needed and under the supervision of a physician.

BreastfeedingConsult your doctor

Consult your doctor to weigh the benefits against potential risks to the infant.

DrivingSafe

This medication is unlikely to affect your ability to drive or operate machinery.

KidneySafe

No dosage adjustment is typically required for patients with renal impairment.

LiverUse with caution

Use with caution in patients with mild to moderate hepatic impairment.

AllergyUnsafe

Do not use if you have a known hypersensitivity to Montelukast or any components of the tablet.

ChildrenSafe

Safe for use in children when prescribed at the appropriate age-based dosage.

ElderlySafe

No specific dosage adjustments are required for the elderly population.

Interactions

With other medicines

Phenobarbital

Moderate

Changes how the medicine is processed

What can happen: Decreased plasma concentration of Montelukast.

What to do: Monitor for reduced efficacy of asthma control.

Rifampicin

Moderate

Changes how the medicine is processed

What can happen: Reduced effect of Montelukast due to enzyme induction.

What to do: Adjust dose if necessary under medical supervision.

Gemfibrozil

Moderate

Changes how the medicine is processed

What can happen: Increased exposure to Montelukast.

What to do: Monitor for increased side effects.

With food and drink

  • General dietMinor

    No significant food interactions are known; it can be taken with or without food.

  • St. John's wortModerate

    May decrease the blood concentrations of Montelukast through enzyme induction.

If you have another condition

  • Liver disease

    May require closer monitoring due to hepatic metabolism of the drug.

  • Phenylketonuria

    Some formulations contain aspartame, a source of phenylalanine.

Effect on laboratory tests

  • Liver function tests

    Potential for elevated transaminases

    Rare cases of elevated liver enzymes have been reported; monitor if symptoms of liver dysfunction occur.

Quick tips

  • Keep a diary of your asthma symptoms to help your doctor assess the effectiveness of Montelukast 10mg Chewable Tablet.
  • Always carry a separate rescue inhaler for sudden asthma attacks, as Montelukast 10mg Chewable Tablet will not provide immediate relief.
  • Inform your doctor if you notice any changes in your mood or behavior while on this medication.
  • Store the tablets in their original packaging to protect them from light and moisture.
  • Avoid known triggers such as cigarette smoke, dust, or pet dander to maximize the benefits of your treatment.

Counselling points

  • AdherenceImportant

    Take Montelukast 10mg Chewable Tablet every evening, even if you feel well, to prevent asthma symptoms.

  • Rescue InhalerImportant

    Always carry your rescue inhaler for sudden breathing difficulties.

  • Mood ChangesGood to know

    Report any unusual changes in behavior, mood, or sleep to your doctor.

  • ChewingOptional

    Ensure the tablet is chewed completely before swallowing.

Monitoring during treatment

Before starting

  • Liver function tests (if history of liver disease exists)

During treatment

  • as needed: Monitor for neuropsychiatric symptoms such as agitation or depression.

What is being watched

  • Asthma control status
  • Frequency of rescue inhaler use
  • Liver enzyme levels (if clinically indicated)

Pharmacokinetics

Absorption
Rapidly absorbed after oral administration.
Bioavailability
Approximately 64% for the 10mg tablet.
Protein binding
Greater than 99%.
Volume of distribution
Average steady-state volume of distribution is 8-11 liters.
Half-life
3 to 6 hours in healthy adults.
Metabolism
Extensively metabolized by the liver via CYP2C8, 2C9, and 3A4 enzymes.
Excretion
Primarily excreted via the bile in the feces.
Onset / duration
Onset of action within 24 hours; effects persist for 24 hours.

Fact box

Chemical class
Quinoline derivative
Habit forming
No
Therapeutic class
Antiasthmatic and anti-inflammatory agent
Action class
Cysteinyl leukotriene receptor antagonist
Storage
Store at room temperature between 20°C and 25°C. Keep away from direct light, heat, and moisture. Keep out of reach of children.
ATC code
R03DC03
Pregnancy category
B

More information

The Role of Leukotriene Antagonists in Asthma

Asthma is fundamentally an inflammatory condition of the airways. While inhaled corticosteroids are the gold standard for controlling this inflammation, leukotriene receptor antagonists like Montelukast offer a distinct mechanism of action. By specifically targeting the cysteinyl leukotrienes, which are potent bronchoconstrictors and inflammatory mediators, Montelukast 10mg Chewable Tablet provides a unique therapeutic pathway. Clinicians often introduce this medication as an add-on therapy for patients who remain symptomatic despite low-to-medium doses of inhaled corticosteroids. It is particularly effective in patients with exercise-induced asthma or those with co-existing allergic rhinitis, as it addresses both upper and lower airway inflammation simultaneously.

Comparing Montelukast 10mg Chewable Tablet with Other Maintenance Therapies

When choosing a maintenance therapy for asthma, clinicians weigh the benefits of inhaled corticosteroids, long-acting beta-agonists, and leukotriene modifiers. Unlike corticosteroids, which can have systemic effects at high doses, Montelukast is generally well-tolerated and does not carry the same risk of growth suppression in children or bone density reduction in the elderly. However, it is generally considered less potent than inhaled corticosteroids for severe asthma. The primary advantage of Montelukast 10mg Chewable Tablet lies in its oral route of administration, which significantly improves compliance for patients who struggle with inhaler technique or find the taste and sensation of inhaled powders unpleasant.

Lifestyle and Management During Treatment

Living with asthma requires a proactive approach beyond just taking medication. While Montelukast 10mg Chewable Tablet helps stabilize the airways, patients must continue to identify and minimize exposure to environmental triggers. Common culprits include dust mites, pollen, pet dander, and cigarette smoke. Maintaining a healthy weight and engaging in regular, moderate exercise can also improve lung function. It is essential to keep a symptom diary, noting the frequency of rescue inhaler use and any triggers that cause flare-ups. This information is invaluable during follow-up visits, allowing your doctor to adjust your treatment plan effectively and ensure you are achieving optimal control of your condition.

Common Misconceptions About Montelukast 10mg Chewable Tablet

A frequent misconception is that Montelukast 10mg Chewable Tablet can be used as a 'quick-fix' for sudden wheezing or tightness in the chest. It is critical to understand that Montelukast has a slow onset of action and does not provide the immediate bronchodilation required during an acute asthma attack. Another common myth is that because it is a 'preventer' medication, it can be stopped as soon as symptoms disappear. Asthma is a chronic condition, and stopping maintenance therapy often leads to a rebound of inflammation and increased risk of severe exacerbations. Always consult your healthcare provider before making any changes to your medication schedule, regardless of how well you feel.

References

  1. Electronic Medicines Compendium. Montelukast 10 mg film-coated tablets, Summary of Product Characteristics.View sourceAccessed
  2. Medical Products Agency. Montelukast STADA 10 mg film-coated tablet, Summary of Product Characteristics.View sourceAccessed
  3. Drugs.com. Montelukast Chewable Tablets, Professional Labeling.View sourceAccessed
  4. US Food and Drug Administration. Montelukast Sodium Label.View sourceAccessed
  5. DailyMed, US National Library of Medicine. Montelukast Sodium Tablet Label.View sourceAccessed
  6. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed

Frequently asked questions about Montelukast

Can I use Montelukast 10mg Chewable Tablet for an acute asthma attack?

No. Montelukast 10mg Chewable Tablet is for long-term maintenance and will not stop an acute asthma attack. Always keep a rescue inhaler available.

Should I take Montelukast 10mg Chewable Tablet with food?

You can take it with or without food, but taking it at the same time each evening helps maintain consistent blood levels.

How long does it take for Montelukast 10mg Chewable Tablet to work?

You may notice improvement within a few days, but it may take several weeks of consistent use to achieve the full therapeutic effect.

Is Montelukast 10mg Chewable Tablet a steroid?

No. Montelukast 10mg Chewable Tablet is a leukotriene receptor antagonist and is not a corticosteroid.

Can I stop taking Montelukast 10mg Chewable Tablet if I feel better?

Do not stop taking it without consulting your doctor, as your asthma symptoms may return if the underlying inflammation is not managed.

Latest